Kampman M - Search Results

1

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø. Grytten N, et al. Among authors: kampman m. Mult Scler. 2020 Oct;26(12):1569-1580. doi: 10.1177/1352458519877244. Epub 2019 Oct 1. Mult Scler. 2020. PMID: 31573834

2

Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.

Harbo HF, Utsi E, Lorentzen AR, Kampman MT, Celius EG, Myhr KM, Lie BA, Mellgren SI, Thorsby E. Harbo HF, et al. Among authors: kampman mt. Tissue Antigens. 2007 Apr;69(4):299-304. doi: 10.1111/j.1399-0039.2007.00803.x. Tissue Antigens. 2007. PMID: 17389012

3

Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway.

Kampman MT, Brustad M. Kampman MT, et al. Neuroepidemiology. 2008;30(3):140-6. doi: 10.1159/000122330. Epub 2008 Apr 2. Neuroepidemiology. 2008. PMID: 18382112 Free article. Review.

4

Environmental risk factors in multiple sclerosis.

Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, Riise T, Wolfson C. Pugliatti M, et al. Among authors: kampman mt. Acta Neurol Scand Suppl. 2008;188:34-40. doi: 10.1111/j.1600-0404.2008.01029.x. Acta Neurol Scand Suppl. 2008. PMID: 18439219 Review.

5

The role of vitamin D in multiple sclerosis.

Kampman MT, Steffensen LH. Kampman MT, et al. J Photochem Photobiol B. 2010 Nov 3;101(2):137-41. doi: 10.1016/j.jphotobiol.2010.04.003. Epub 2010 Apr 21. J Photochem Photobiol B. 2010. PMID: 20471852 Review.

6

Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?

Kampman MT, Eriksen EF, Holmøy T. Kampman MT, et al. Acta Neurol Scand Suppl. 2011;(191):44-9. doi: 10.1111/j.1600-0404.2011.01543.x. Acta Neurol Scand Suppl. 2011. PMID: 21711256 Review.

7

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.

Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L. Kampman MT, et al. Mult Scler. 2012 Aug;18(8):1144-51. doi: 10.1177/1352458511434607. Epub 2012 Feb 21. Mult Scler. 2012. PMID: 22354743 Clinical Trial.

8

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J; SOLAR Study Group. Grimaldi L, et al. Neurology. 2012 Mar 13;78(11):841. doi: 10.1212/01.wnl.0000413180.13413.ce. Neurology. 2012. PMID: 22411961 No abstract available.

9

Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.

Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF. Maniaol AH, et al. Among authors: kampman mt. PLoS One. 2012;7(5):e36603. doi: 10.1371/journal.pone.0036603. Epub 2012 May 9. PLoS One. 2012. PMID: 22590574 Free PMC article. Clinical Trial.

10

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT. Grytten N, et al. Mult Scler. 2013 Jul;19(8):1028-34. doi: 10.1177/1352458512471094. Epub 2012 Dec 20. Mult Scler. 2013. PMID: 23257620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page